Chandigarh, Sep 7 (PTI) The Department of Haematology at Command Hospital (Western Command), Chandimandir, has administered its first CAR-T cell therapy to a 16-year-old patient suffering from relapsed refractory B-cell acute lymphoblastic leukaemia, the Army said on Monday.
The hospital is the first Command Hospital other than Army Hospital (R&R), Delhi, to offer the advanced cellular therapy, according to an official statement.
CAR-T cell therapy involves collecting a patient’s T-cells, genetically modifying them by introducing a chimeric antigen receptor (CAR) and reinfusing them to enable the cells to recognise and attack cancer cells, it said.
The therapy offers a treatment option for patients with relapsed or refractory blood cancers, the statement said.
The achievement enhances the indigenous capability to manage complex haematological malignancies within the armed forces’ healthcare system and strengthens comprehensive cancer care, it said.
The statement said the haematology centre, established recently, has performed nine successful bone marrow transplants and has now expanded to cellular therapy.
Maj Gen Harkirat Singh, Commandant, Command Hospital (Western Command), said the achievement was the result of sustained clinical efforts by the centre.
“The latest accomplishment places the centre at the forefront of advanced cellular therapies and opens a new chapter in the management of difficult-to-treat haematological malignancies,” the statement said.
The achievement reflects the Indian Army’s commitment to adopting advanced medical technologies and strengthening specialised clinical capabilities, it said. PTI SUN MDO MDO
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.